Ikarian Capital »

Proqr Thrapeutics N V shs euro shares owned by Ikarian Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $803k 484k 1.66
2024-03-31 $1.1M 484k 2.27
2023-12-31 $936k 473k 1.98
2023-09-30 $614k 473k 1.30
2023-06-30 $766k 473k 1.62
2023-03-31 $1.0M 473k 2.13
2022-12-31 $1.6M 423k 3.70

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ghost Tree Capital
Macquarie Group
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Monaco Asset Management SAM
Franklin Street Advisors
Millennium Management
Two Sigma Advisers
Susquehanna International
Squarepoint Ops
Morgan Stanley

View all funds holding Proqr Thrapeutics N V shs euro